+
Source: Cook K. Anemias. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 10th ed. New York, NY: McGraw-Hill; 2017. http://accesspharmacy.mhmedical.com/content.aspx?bookid=1861§ionid=146070326. Accessed January 30, 2017.
++
++
++
Hypoproliferative.
Maturation disorders.
Cytoplasmic defects (thalassemia, iron deficiency, sideroblastic)
Nuclear maturation defect (folate deficiency, B12 deficiency, refractory anemia)
Hemorrhage/hemolysis.
++
+++
CLINICAL PRESENTATION
++
++
+++
MEANS OF CONFIRMATION AND DIAGNOSIS
++
++
Complete blood count (CBC) (Table 1)
Focus on Hb, hematocrit (Hct), and RBC indices.
May initially be normal and then decrease as anemia progresses.
Serum iron (low with IDA and anemia of inflammation (AI))
Ferritin.
Low with IDA and normal to increased in AI
Earliest and most sensitive indicator of iron deficiency.
Interpret in conjunction with transferring saturation and total iron-binding capacity (TIBC)
TIBC (high with IDA and low or normal in AI)
Mean cell volume is elevated in vitamin B12 deficiency and folate deficiency.
Vitamin B12 and folate levels are low in their respective types of anemia.
Homocysteine is elevated in vitamin B12 deficiency and folate deficiency.
Methylmalonic acid is elevated in vitamin B12 deficiency.
++